AbbVie ABBV
NYSE ABBV
$276.48 +4.06 (+1.49%)
At close: Oct 9, 2026 · 4:00 PM EDT

AbbVie (ABBV) Net Income (2012 - 2026)

Updated

AbbVie (ABBV) posted Net Income of $3.62 billion for Q2 2026, up 284.3% from $941 million a year earlier and up 418.8% from the prior quarter.

Analysis

AbbVie (ABBV) Net Income (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income at AbbVie was $6.32 billion, up 67.5% year-over-year; for FY2025, it was $4.23 billion, down 1.2% from FY2024.

  • Annual Net Income has declined for three consecutive years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • In prior years, AbbVie's Net Income was $4.29 billion in FY2024 (-12.0%), $4.87 billion in FY2023 (-58.9%), $11.85 billion in FY2022 (+2.6%) and $11.55 billion in FY2021 (+149.9%).
  • The Q2 2026 figure stands as the highest quarterly Net Income since Q3 2022.
  • On a year-over-year basis, Net Income increased in 1 of the last six quarters, with growth averaging 16.8%.
  • The strongest year-over-year quarter for Net Income in the past five years was Q1 2024, with growth of 469.3%; the weakest was Q1 2023, with a decline of 94.6%.
  • According to Business Quant data, Net Income for the three prior quarters was $697 million (Q1 2026), $1.82 billion (Q4 2025) and $188 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 5.53 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.62 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 2.51 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -10.50 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -248.00 Mn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.62 Bn
Mar 31, 2026 697.00 Mn
Dec 31, 2025 1.82 Bn
Sep 30, 2025 188.00 Mn
Jun 30, 2025 941.00 Mn
Mar 31, 2025 1.29 Bn
Dec 31, 2024 -22.00 Mn
Sep 30, 2024 1.56 Bn
Jun 30, 2024 1.37 Bn
Mar 31, 2024 1.37 Bn
Dec 31, 2023 822.00 Mn
Sep 30, 2023 1.78 Bn
Jun 30, 2023 2.03 Bn
Mar 31, 2023 241.00 Mn
Dec 31, 2022 2.47 Bn
Sep 30, 2022 3.95 Bn
Jun 30, 2022 928.00 Mn
Mar 31, 2022 4.49 Bn
Dec 31, 2021 4.04 Bn
Sep 30, 2021 3.18 Bn
API Access

AbbVie Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=ABBV&period=max&api_key=YOUR_API_KEY